-
1
المؤلفون: Kurt S. Zänker, Isabel Alicia Luthy, Ezequiel Mariano Rivero, Ariana Bruzzone, Cecilia Pérez Piñero, Lucía Gargiulo, Frank Entschladen
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Lung Neoplasms, MDA-MB-231, Mice, SCID, Metastasis, β adrenoceptor, Mice, Cell Movement, Mice, Inbred NOD, Drug Discovery, Neoplasm Metastasis, IBH-6, Mda mb 231, Patología, Beta adrenoceptor, Bioquímica y Biología Molecular, Adrenergic Agonists, Propranolol, Extracellular Matrix, Drug Combinations, Medicina Básica, Oncology, Female, Proteoglycans, Collagen, medicine.medical_specialty, CIENCIAS MÉDICAS Y DE LA SALUD, Inmunología, Breast Neoplasms, BETA-ADRENOCEPTORS, 03 medical and health sciences, BREAST CANCER, Cell Line, Tumor, Internal medicine, medicine, Animals, Humans, Albuterol, Neoplasm Invasiveness, Adrenergic agonist, Cell Proliferation, SALBUTAMOL, Pharmacology, Migration invasion, business.industry, Cancer, medicine.disease, Molecular biology, ADRENOCEPTORS, 030104 developmental biology, Endocrinology, METASTASIS, Laminin, business, Human breast
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5963e2f24f6918e6091c59e1140996f4Test
http://www.eurekaselect.com/151233/articleTest -
2دورية أكاديمية
المؤلفون: Rivero, Ezequiel Mariano, Perez, Cecilia, Gargiulo, Lucía, Entschladen, Frank, Zänker, Kurt, Bruzzone, Ariana, Luthy, Isabel Alicia
مصطلحات موضوعية: BREAST CANCER, METASTASIS, BETA-ADRENOCEPTORS, SALBUTAMOL, MDA-MB-231, IBH-6, https://purl.org/becyt/ford/3.1Test, https://purl.org/becyt/ford/3Test
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/url/https://www.ingentaconnect.com/contentone/ben/ccdt/2017/00000017/00000008/art00008Test; http://hdl.handle.net/11336/63602Test; Rivero, Ezequiel Mariano; Perez, Cecilia; Gargiulo, Lucía; Entschladen, Frank; Zänker, Kurt; et al.; The β2-adrenergic agonist salbutamol inhibits migration, invasion and metastasis of the human breast cancer MDA-MB- 231 cell line; Bentham Science Publishers; Current Cancer Drug Targets; 17; 8; 9-2017; 756-766; CONICET Digital; CONICET
